Skip to main content
Premium Trial:

Request an Annual Quote

BioFocus Joins Argenta, Genentech Research Alliance

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Argenta, a division of Galapagos that specializes in computer-aided drug design, today said that BioFocus has joined its collaboration with Genentech to discover new chemical entities for targets picked by the biopharmaceutical firm.

BioFocus, which also is a division of Galapagos, will provide Genentech with integrated medicinal chemistry, in vitro biology, and ADME services. BioFocus' discovery platform includes cell-based assays, structural biology, chemogenomic and informatics tools, among other capabilities.

Argenta, which was acquired by Galapagos this past February, has been providing drug discovery services for Genentech since 2005.

Terms of the alliance have not been disclosed.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.